{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DNA repair", "apoptosis", "drug transporters", "epithelial\u2013mesenchymal transition", "glioblastoma", "metabolism", "microRNAs", "multidrug resistance"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35804989", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "30"}], "Language": ["eng"], "ELocationID": ["3217", "10.3390/cancers14133217"], "Journal": {"ISSN": "2072-6694", "JournalIssue": {"Volume": "14", "Issue": "13", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "30"}}, "Title": "Cancers", "ISOAbbreviation": "Cancers (Basel)"}, "ArticleTitle": "The Role of microRNAs in Multidrug Resistance of Glioblastoma.", "Abstract": {"AbstractText": ["Glioblastoma (GBM) is an aggressive brain tumor that develops from neuroglial stem cells and represents a highly heterogeneous group of neoplasms. These tumors are predominantly correlated with a dismal prognosis and poor quality of life. In spite of major advances in developing novel and effective therapeutic strategies for patients with glioblastoma, multidrug resistance (MDR) is considered to be the major reason for treatment failure. Several mechanisms contribute to MDR in GBM, including upregulation of MDR transporters, alterations in the metabolism of drugs, dysregulation of apoptosis, defects in DNA repair, cancer stem cells, and epithelial-mesenchymal transition. MicroRNAs (miRNAs) are a large class of endogenous RNAs that participate in various cell events, including the mechanisms causing MDR in glioblastoma. In this review, we discuss the role of miRNAs in the regulation of the underlying mechanisms in MDR glioblastoma which will open up new avenues of inquiry for the treatment of glioblastoma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5166/15731, Iran."}], "LastName": "Mahinfar", "ForeName": "Parvaneh", "Initials": "P"}, {"Identifier": ["0000-0001-5904-2596"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5166/15731, Iran."}, {"Identifier": [], "Affiliation": "Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran 175-14115, Iran."}], "LastName": "Mansoori", "ForeName": "Behnaz", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Yasuj University of Medical Sciences, Yasuj 7591994799, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj 7591994799, Iran."}], "LastName": "Rostamzadeh", "ForeName": "Davoud", "Initials": "D"}, {"Identifier": ["0000-0002-8642-6795"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5166/15731, Iran."}], "LastName": "Baradaran", "ForeName": "Behzad", "Initials": "B"}, {"Identifier": ["0000-0003-4174-4586"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR, China."}], "LastName": "Cho", "ForeName": "William C", "Initials": "WC"}, {"Identifier": ["0000-0001-9444-7134"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Molecular & Cellular Oncogenesis Program, Philadelphia, PA 19104, USA."}], "LastName": "Mansoori", "ForeName": "Behzad", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cancers (Basel)", "NlmUniqueID": "101526829", "ISSNLinking": "2072-6694"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Desjardins A., Gromeier M., Herndon J.E., Beaubier N., Bolognesi D.P., Friedman A.H., Friedman H.S., McSherry F., Muscat A.M., Nair S., et al. Recurrent Glioblastoma Treated with Recombinant Poliovirus. N. Engl. J. Med. 2018;379:150\u2013161. doi: 10.1056/NEJMoa1716435.", "ArticleIdList": ["10.1056/NEJMoa1716435", "PMC6065102", "29943666"]}, {"Citation": "Hanif F., Muzaffar K., Perveen K., Malhi S.M., Simjee S.U. Glioblastoma Multiforme: A Review of Its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pacific J. Cancer Prev. 2017;18:3\u20139. doi: 10.22034/APJCP.2017.18.1.3.", "ArticleIdList": ["10.22034/APJCP.2017.18.1.3", "PMC5563115", "28239999"]}, {"Citation": "Shergalis A., Bankhead A., Luesakul U., Muangsin N., Neamati N. Current Challenges and Opportunities in Treating Glioblastomas. Pharmacol. Rev. 2018;70:412\u2013445. doi: 10.1124/pr.117.014944.", "ArticleIdList": ["10.1124/pr.117.014944", "PMC5907910", "29669750"]}, {"Citation": "Louis D.N., Perry A., Wesseling P., Brat D.J., Cree I.A., Figarella-Branger D., Hawkins C., Ng H.K., Pfister S.M., Reifenberger G., et al. The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary. Neuro. Oncol. 2021;23:1231\u20131251. doi: 10.1093/neuonc/noab106.", "ArticleIdList": ["10.1093/neuonc/noab106", "PMC8328013", "34185076"]}, {"Citation": "Shahneh F.Z., Valiyari S., Baradaran B., Abdolalizadeh J., Bandehagh A., Azadmehr A., Hajiaghaee R. Inhibitory and Cytotoxic Activities of Salvia Officinalis l. Extract on Human Lymphoma and Leukemia Cells by Induction of Apoptosis. Adv. Pharm. Bull. 2013;3:51\u201355. doi: 10.5681/apb.2013.009.", "ArticleIdList": ["10.5681/apb.2013.009", "PMC3846054", "24312812"]}, {"Citation": "Wang Z., Zhang H., Xu S., Liu Z., Cheng Q. The Adaptive Transition of Glioblastoma Stem Cells and Its Implications on Treatments. Signal Transduct. Target. Ther. 2021;6:124. doi: 10.1038/s41392-021-00491-w.", "ArticleIdList": ["10.1038/s41392-021-00491-w", "PMC7985200", "33753720"]}, {"Citation": "Fisher J.P., Adamson D.C. Current FDA-Approved Therapies for High-Grade Malignant Gliomas. Biomedicines. 2021;9:324. doi: 10.3390/biomedicines9030324.", "ArticleIdList": ["10.3390/biomedicines9030324", "PMC8004675", "33810154"]}, {"Citation": "Olivier C., Oliver L., Lalier L., Vallette F.M. Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Front. Mol. Biosci. 2021;7:620677. doi: 10.3389/fmolb.2020.620677.", "ArticleIdList": ["10.3389/fmolb.2020.620677", "PMC7873048", "33585565"]}, {"Citation": "Bukowski K., Kciuk M., Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int. J. Mol. Sci. 2020;21:3233. doi: 10.3390/ijms21093233.", "ArticleIdList": ["10.3390/ijms21093233", "PMC7247559", "32370233"]}, {"Citation": "Mansoori B., Mohammadi A., Davudian S., Shirjang S., Baradaran B. The Different Mechanisms of Cancer Drug Resistance: A Brief Review. Adv. Pharm. Bull. 2017;7:339\u2013348. doi: 10.15171/apb.2017.041.", "ArticleIdList": ["10.15171/apb.2017.041", "PMC5651054", "29071215"]}, {"Citation": "Hamed A.R., Abdel-Azim N.S., Shams K.A., Hammouda F.M. Targeting Multidrug Resistance in Cancer by Natural Chemosensitizers. Bull. Natl. Res. Cent. 2019;43:8. doi: 10.1186/s42269-019-0043-8.", "ArticleIdList": ["10.1186/s42269-019-0043-8"]}, {"Citation": "Zheng T., Wang J., Chen X., Liu L. Role of MicroRNA in Anticancer Drug Resistance. Int. J. Cancer. 2010;126:2\u201310. doi: 10.1002/ijc.24782.", "ArticleIdList": ["10.1002/ijc.24782", "19634138"]}, {"Citation": "Hassn Mesrati M., Behrooz A.B., Abuhamad A.Y., Syahir A. Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer. Cells. 2020;9:1236. doi: 10.3390/cells9051236.", "ArticleIdList": ["10.3390/cells9051236", "PMC7291262", "32429463"]}, {"Citation": "Wang X., Zhang H., Chen X. Drug Resistance and Combating Drug Resistance in Cancer. Cancer Drug Resist. 2019;2:141\u2013160. doi: 10.20517/cdr.2019.10.", "ArticleIdList": ["10.20517/cdr.2019.10", "PMC8315569", "34322663"]}, {"Citation": "Vaghari-Tabari M., Majidinia M., Moein S., Qujeq D., Asemi Z., Alemi F., Mohamadzadeh R., Targhazeh N., Safa A., Yousefi B. MicroRNAs and Colorectal Cancer Chemoresistance: New Solution for Old Problem. Life Sci. 2020;259:118255. doi: 10.1016/j.lfs.2020.118255.", "ArticleIdList": ["10.1016/j.lfs.2020.118255", "32818543"]}, {"Citation": "Ward R.A., Fawell S., Floc\u2019h N., Flemington V., McKerrecher D., Smith P.D. Challenges and Opportunities in Cancer Drug Resistance. Chem. Rev. 2021;121:3297\u20133351. doi: 10.1021/acs.chemrev.0c00383.", "ArticleIdList": ["10.1021/acs.chemrev.0c00383", "32692162"]}, {"Citation": "Chen M., Medarova Z., Moore A. Role of Micrornas in Glioblastoma. Oncotarget. 2021;12:1707\u20131723. doi: 10.18632/oncotarget.28039.", "ArticleIdList": ["10.18632/oncotarget.28039", "PMC8378762", "34434499"]}, {"Citation": "Nikolaou M., Pavlopoulou A., Georgakilas A.G., Kyrodimos E. The Challenge of Drug Resistance in Cancer Treatment: A Current Overview. Clin. Exp. Metastasis. 2018;35:309\u2013318. doi: 10.1007/s10585-018-9903-0.", "ArticleIdList": ["10.1007/s10585-018-9903-0", "29799080"]}, {"Citation": "Chernov A.N., Alaverdian D.A., Galimova E.S., Renieri A., Frullanti E., Meloni I., Shamova O.V. The Phenomenon of Multidrug Resistance in Glioblastomas. Hematol. Oncol. Stem Cell Ther. 2021. in press .", "ArticleIdList": ["10.1016/j.hemonc.2021.05.006", "34216549"]}, {"Citation": "Li Y.J., Lei Y.H., Yao N., Wang C.R., Hu N., Ye W.C., Zhang D.M., Chen Z.S. Autophagy and Multidrug Resistance in Cancer. Chin. J. Cancer. 2017;36:52. doi: 10.1186/s40880-017-0219-2.", "ArticleIdList": ["10.1186/s40880-017-0219-2", "PMC5482965", "28646911"]}, {"Citation": "Feng Z., Liu D., Wang L., Wang Y., Zang Z., Liu Z., Song B., Gu L., Fan Z., Yang S., et al. A Putative Efflux Transporter of the ABC Family, YbhFSR, in Escherichia Coli Functions in Tetracycline Efflux and Na+(Li+)/H+ Transport. Front. Microbiol. 2020;11:556. doi: 10.3389/fmicb.2020.00556.", "ArticleIdList": ["10.3389/fmicb.2020.00556", "PMC7190983", "32390957"]}, {"Citation": "Vivo I., Characterization P., Dual P., Molinari A., Bugli F., Sanguinetti M., Torelli R., Martini M., Maccari L., Valoti M., et al. A New Strategy for Glioblastoma Treatment: In Vitro. Cancers. 2019;11:848.", "ArticleIdList": ["PMC6628362", "31248184"]}, {"Citation": "Arya V., Kiser J.J. Role of Transporters in Drug Development. J. Clin. Pharmacol. 2016;56:S7\u2013S10. doi: 10.1002/jcph.784.", "ArticleIdList": ["10.1002/jcph.784", "27385180"]}, {"Citation": "Bart A.G., Morais G., Vangala V.R., Loadman P.M., Pors K., Scott E.E. Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents. Drug Metab. Dispos. 2022;50:49\u201357. doi: 10.1124/dmd.121.000642.", "ArticleIdList": ["10.1124/dmd.121.000642", "PMC8969195", "34607808"]}, {"Citation": "Tsai Y.T., Lo W.L., Chen P.Y., Ko C.Y., Chuang J.Y., Kao T.J., Yang W.B., Chang K.Y., Hung C.Y., Kikkawa U., et al. Reprogramming of Arachidonate Metabolism Confers Temozolomide Resistance to Glioblastoma through Enhancing Mitochondrial Activity in Fatty Acid Oxidation. J. Biomed. Sci. 2022;29:21. doi: 10.1186/s12929-022-00804-3.", "ArticleIdList": ["10.1186/s12929-022-00804-3", "PMC8952270", "35337344"]}, {"Citation": "Kuban W., Daniel W.A. Cytochrome P450 Expression and Regulation in the Brain. Drug Metab. Rev. 2021;53:1\u201329. doi: 10.1080/03602532.2020.1858856.", "ArticleIdList": ["10.1080/03602532.2020.1858856", "33356626"]}, {"Citation": "Sanchez-Spitman A.B., Swen J.J., Dezentj\u00e9 V.O., Moes D.J.A.R., Gelderblom H., Guchelaar H.J. Effect of CYP2C19 Genotypes on Tamoxifen Metabolism and Early-Breast Cancer Relapse. Sci. Rep. 2021;11:415. doi: 10.1038/s41598-020-79972-x.", "ArticleIdList": ["10.1038/s41598-020-79972-x", "PMC7801676", "33432065"]}, {"Citation": "Aubrey B.J., Kelly G.L., Janic A., Herold M.J., Strasser A. How Does P53 Induce Apoptosis and How Does This Relate to P53-Mediated Tumour Suppression? Cell Death Differ. 2018;25:104\u2013113. doi: 10.1038/cdd.2017.169.", "ArticleIdList": ["10.1038/cdd.2017.169", "PMC5729529", "29149101"]}, {"Citation": "Mantovani F., Collavin L., Del Sal G. Mutant P53 as a Guardian of the Cancer Cell. Cell Death Differ. 2019;26:199\u2013212. doi: 10.1038/s41418-018-0246-9.", "ArticleIdList": ["10.1038/s41418-018-0246-9", "PMC6329812", "30538286"]}, {"Citation": "Zhang Y., Dube C., Gibert M., Cruickshanks N., Wang B., Coughlan M., Yang Y., Setiady I., Deveau C., Saoud K., et al. The P53 Pathway in Glioblastoma. Cancers. 2018;10:297. doi: 10.3390/cancers10090297.", "ArticleIdList": ["10.3390/cancers10090297", "PMC6162501", "30200436"]}, {"Citation": "Neophytou C.M., Trougakos I.P., Erin N., Papageorgis P. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers. 2021;13:4363. doi: 10.3390/cancers13174363.", "ArticleIdList": ["10.3390/cancers13174363", "PMC8430856", "34503172"]}, {"Citation": "Morris J.L., Gillet G., Prudent J., Popgeorgiev N. Bcl-2 Family of Proteins in the Control of Mitochondrial Calcium Signalling: An Old Chap with New Roles. Int. J. Mol. Sci. 2021;22:3730. doi: 10.3390/ijms22073730.", "ArticleIdList": ["10.3390/ijms22073730", "PMC8038216", "33918511"]}, {"Citation": "Liao W.H., Hsiao M.Y., Kung Y., Huang A.P.H., Chen W.S. Investigation of the Therapeutic Effect of Doxorubicin Combined With Focused Shockwave on Glioblastoma. Front. Oncol. 2021;11:711088. doi: 10.3389/fonc.2021.711088.", "ArticleIdList": ["10.3389/fonc.2021.711088", "PMC8356050", "34395286"]}, {"Citation": "Maliyakkal N., Appadath Beeran A., Udupa N. Nanoparticles of Cisplatin Augment Drug Accumulations and Inhibit Multidrug Resistance Transporters in Human Glioblastoma Cells. Saudi Pharm. J. 2021;29:857\u2013873. doi: 10.1016/j.jsps.2021.07.001.", "ArticleIdList": ["10.1016/j.jsps.2021.07.001", "PMC8363105", "34408546"]}, {"Citation": "Annovazzi L., Mellai M., Schiffer D. Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma. Cancers. 2017;9:57. doi: 10.3390/cancers9060057.", "ArticleIdList": ["10.3390/cancers9060057", "PMC5483876", "28587121"]}, {"Citation": "Majidinia M., Yousefi B. Long non-coding RNAs in cancer drug resistance development. DNA Repair. 2016;45:25\u201333. doi: 10.1016/j.dnarep.2016.06.003.", "ArticleIdList": ["10.1016/j.dnarep.2016.06.003", "27427176"]}, {"Citation": "Phi L.T.H., Sari I.N., Yang Y.G., Lee S.H., Jun N., Kim K.S., Lee Y.K., Kwon H.Y. Cancer Stem Cells (CSCs) in Drug Resistance and Their Therapeutic Implications in Cancer Treatment. Stem Cells Int. 2018;2018:5416923. doi: 10.1155/2018/5416923.", "ArticleIdList": ["10.1155/2018/5416923", "PMC5850899", "29681949"]}, {"Citation": "Suresh R., Ali S., Ahmad A., Philip P.A., Sarkar F.H. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Springer; Berlin/Heidelberg, Germany: 2016. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer; pp. 57\u201374.", "ArticleIdList": ["10.1007/978-3-319-24932-2", "26703799"]}, {"Citation": "Ong D.S.T., Hu B., Ho Y.W., Sauv\u00e9 C.E.G., Bristow C.A., Wang Q., Multani A.S., Chen P., Nezi L., Jiang S., et al. PAF Promotes Stemness and Radioresistance of Glioma Stem Cells. Proc. Natl. Acad. Sci. USA. 2017;114:E9085\u2013E9095. doi: 10.1073/pnas.1708122114.", "ArticleIdList": ["10.1073/pnas.1708122114", "PMC5664518", "29073105"]}, {"Citation": "Gravina G.L., Mancini A., Marampon F., Colapietro A., Delle Monache S., Sferra R., Vitale F., Richardson P.J., Patient L., Burbidge S., et al. The Brain-Penetrating CXCR4 Antagonist, PRX177561, Increases the Antitumor Effects of Bevacizumab and Sunitinib in Preclinical Models of Human Glioblastoma. J. Hematol. Oncol. 2017;10:5. doi: 10.1186/s13045-016-0377-8.", "ArticleIdList": ["10.1186/s13045-016-0377-8", "PMC5217647", "28057017"]}, {"Citation": "Hill C., Wang Y. The Importance of Epithelial-Mesenchymal Transition and Autophagy in Cancer Drug Resistance. Cancer Drug Resist. 2020;3:38\u201347. doi: 10.20517/cdr.2019.75.", "ArticleIdList": ["10.20517/cdr.2019.75", "PMC7100899", "32226927"]}, {"Citation": "Shibue T., Weinberg R.A. EMT, CSCs, and Drug Resistance: The Mechanistic Link and Clinical Implications. Nat. Publ. Gr. 2017;14:611\u2013629. doi: 10.1038/nrclinonc.2017.44.", "ArticleIdList": ["10.1038/nrclinonc.2017.44", "PMC5720366", "28397828"]}, {"Citation": "Xie Y.K., Huo S.F., Zhang G., Zhang F., Lian Z.P., Tang X.L., Jin C. CDA-2 Induces Cell Differentiation through Suppressing Twist/SLUG Signaling via MiR-124 in Glioma. J. Neurooncol. 2012;110:179\u2013186. doi: 10.1007/s11060-012-0961-x.", "ArticleIdList": ["10.1007/s11060-012-0961-x", "22918790"]}, {"Citation": "Iwadate Y. Epithelial-Mesenchymal Transition in Glioblastoma Progression. Oncol. Lett. 2016;11:1615\u20131620. doi: 10.3892/ol.2016.4113.", "ArticleIdList": ["10.3892/ol.2016.4113", "PMC4774466", "26998052"]}, {"Citation": "Setlai B.P., Hull R., Reis R.M., Agbor C., Ambele M.A., Mulaudzi T.V., Dlamini Z. MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma. Genes. 2022;13:244. doi: 10.3390/genes13020244.", "ArticleIdList": ["10.3390/genes13020244", "PMC8872331", "35205289"]}, {"Citation": "Brook O.R. Radiology Structured Reporting Handbook. Thieme; New York, NY, USA: 2021. 34 Fibrotic Lung Disease; pp. 1\u201326.", "ArticleIdList": ["10.1055/b-0041-182021"]}, {"Citation": "Kucherenko M.M., Shcherbata H.R. miRNA Targeting and Alternative Splicing in the Stress Response\u2014Events Hosted by Membrane-Less Compartments. J. Cell Sci. 2018;131:jcs202002. doi: 10.1242/jcs.202002.", "ArticleIdList": ["10.1242/jcs.202002", "29444950"]}, {"Citation": "Gajda E., Godlewska M., Mariak Z., Nazaruk E. Combinatory Treatment with MiR-7-5p and Drug-Loaded Cubosomes E Ff Ectively Impairs Cancer Cells. Int. J. Mol. Sci. 2020;21:5039. doi: 10.3390/ijms21145039.", "ArticleIdList": ["10.3390/ijms21145039", "PMC7404280", "32708846"]}, {"Citation": "Keeler J.R., Roth E.A., Neuser B.L., Spitsbergen J.M., Waters D.J.M., Vianney J.M. The Neurochemistry and Social Flow of Singing: Bonding and Oxytocin. Front. Hum. Neurosci. 2015;9:518. doi: 10.3389/fnhum.2015.00518.", "ArticleIdList": ["10.3389/fnhum.2015.00518", "PMC4585277", "26441614"]}, {"Citation": "Huang S., Ali N., Zhong L., Shi J. MicroRNAs as Biomarkers for Human Glioblastoma: Progress and Potential. Acta Pharmacol. Sin. 2018;39:1405\u20131413. doi: 10.1038/aps.2017.173.", "ArticleIdList": ["10.1038/aps.2017.173", "PMC6289388", "29417946"]}, {"Citation": "Hallal S., Mallawaaratchy D.M., Wei H., Ebrahimkhani S., Stringer B.W., Day B.W., Boyd A.W. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via P53 and MYC Signaling Pathways. Mol. Neurobiol. 2019;56:4566\u20134581. doi: 10.1007/s12035-018-1385-1.", "ArticleIdList": ["10.1007/s12035-018-1385-1", "PMC6505517", "30353492"]}, {"Citation": "Yi G., Feng W., Zhou Q., Liu Y., Qi S. The Impact of MMP-2 and Its Specific Inhibitor TIMP-2 Expression on the WHO Grade and Prognosis of Gliomas in Chinese Population: A Meta-Analysis. Mol. Neurobiol. 2016;54:22\u201330. doi: 10.1007/s12035-015-9539-x.", "ArticleIdList": ["10.1007/s12035-015-9539-x", "PMC5219888", "26729052"]}, {"Citation": "Breznik B., Motaln H., Vittori M., Rotter A., Lah T. Mesenchymal Stem Cells Differentially Affect the Invasion of Distinct Glioblastoma Cell Lines. Oncotarget. 2017;8:25482\u201325499. doi: 10.18632/oncotarget.16041.", "ArticleIdList": ["10.18632/oncotarget.16041", "PMC5421945", "28424417"]}, {"Citation": "Kora\u0107 P., Antica M., Matuli\u0107 M. Mir-7 in Cancer Development. Biomedicines. 2021;9:325. doi: 10.3390/biomedicines9030325.", "ArticleIdList": ["10.3390/biomedicines9030325", "PMC8004586", "33806891"]}, {"Citation": "Xu F., Li F., Zhang W., Jia P. Growth of Glioblastoma Is Inhibited by MiR-133-Mediated EGFR Suppression. Tumor Biol. 2015;36:9553\u20139558. doi: 10.1007/s13277-015-3724-4.", "ArticleIdList": ["10.1007/s13277-015-3724-4", "26138587"]}, {"Citation": "Florian A.I., Timis T., Buruian A., Florian I., Hraps I., Mihu C.M., Micl M., Sergiu S. The Roles of MiRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations. Int. J. Mol. Sci. 2020;21:1950.", "ArticleIdList": ["PMC7139390", "32178454"]}, {"Citation": "Li X., Liu Y., Granberg K.J., Wang Q., Moore L.M., Ji P., Gumin J., Sulman E.P., Calin G.A., Haapasalo H., et al. Two Mature Products of MIR-491 Coordinate to Suppress Key Cancer Hallmarks in Glioblastoma. Oncogene. 2015;34:1619\u20131628. doi: 10.1038/onc.2014.98.", "ArticleIdList": ["10.1038/onc.2014.98", "PMC4205227", "24747968"]}, {"Citation": "Zirak R.G., Tajik H., Asadi J. The Role of Micro RNAs in Regulating PI3K/AKT Signaling Pathways in Glioblastoma. Iran. J. Pathol. 2022;17:122\u2013136. doi: 10.30699/ijp.2022.539029.2726.", "ArticleIdList": ["10.30699/ijp.2022.539029.2726", "PMC9013863", "35463721"]}, {"Citation": "Ma Z., Liu T., Huang W., Liu H., Zhang H.M., Li Q., Chen Z., Guo A.Y. MicroRNA Regulatory Pathway Analysis Identifies MiR-142-5p as a Negative Regulator of TGF-\u00df Pathway via Targeting SMAD3. Oncotarget. 2016;7:71504\u201371513. doi: 10.18632/oncotarget.12229.", "ArticleIdList": ["10.18632/oncotarget.12229", "PMC5342096", "27683030"]}, {"Citation": "Xu B., Mei J., Ji W., Huo Z., Bian Z., Jiao J., Li X., Sun J., Shao J. MicroRNAs Involved in the EGFR Pathway in Glioblastoma. Biomed. Pharmacother. 2021;134:111115. doi: 10.1016/j.biopha.2020.111115.", "ArticleIdList": ["10.1016/j.biopha.2020.111115", "33341046"]}, {"Citation": "Neurochemistry J.O.F. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met. J. Neurochem. 2015;135:274\u2013286. doi: 10.1111/jnc.13272.", "ArticleIdList": ["10.1111/jnc.13272", "26250785"]}, {"Citation": "Bouzari B., Mohammadi S., Bokov D.O., Krasnyuk I.I., Hosseini-Fard S.R., Hajibaba M., Mirzaei R., Karampoor S. Angioregulatory Role of MiRNAs and Exosomal MiRNAs in Glioblastoma Pathogenesis. Biomed. Pharmacother. 2022;148:112760. doi: 10.1016/j.biopha.2022.112760.", "ArticleIdList": ["10.1016/j.biopha.2022.112760", "35228062"]}, {"Citation": "Bhaskaran V., Nowicki M.O., Idriss M., Jimenez M.A., Lugli G., Hayes J.L., Mahmoud A.B., Zane R.E., Passaro C., Ligon K.L., et al. The Functional Synergism of MicroRNA Clustering Provides Therapeutically Relevant Epigenetic Interference in Glioblastoma. Nat. Commun. 2019;10:442. doi: 10.1038/s41467-019-08390-z.", "ArticleIdList": ["10.1038/s41467-019-08390-z", "PMC6347618", "30683859"]}, {"Citation": "Gong W., Zheng J., Liu X., Ma J., Liu Y., Xue Y. Knockdown of NEAT1 Restrained the Malignant Progression of Glioma Stem Cells by Activating MicroRNA Let-7e. Oncotarget. 2016;7:62208. doi: 10.18632/oncotarget.11403.", "ArticleIdList": ["10.18632/oncotarget.11403", "PMC5308721", "27556696"]}, {"Citation": "Wang M., Zhao M., Guo Q., Lou J., Wang L. Non-Small Cell Lung Cancer Cell\u2013Derived Exosomal MiR-17-5p Promotes Osteoclast Differentiation by Targeting PTEN. Exp. Cell Res. 2021;408:112834. doi: 10.1016/j.yexcr.2021.112834.", "ArticleIdList": ["10.1016/j.yexcr.2021.112834", "34537206"]}, {"Citation": "Wang W., Hao Y., Zhang A., Yang W., Wei W., Wang G., Jia Z. MiR-19a/b Promote EMT and Proliferation in Glioma Cells via SEPT7-AKT-NF-\u039aB Pathway. Mol. Ther.-Oncolytics. 2021;20:290\u2013305. doi: 10.1016/j.omto.2021.01.005.", "ArticleIdList": ["10.1016/j.omto.2021.01.005", "PMC7868923", "33614912"]}, {"Citation": "Cai J., Zhao J., Zhang N., Xu X., Li R., Yi Y., Fang L., Zhang L., Li M., Wu J., et al. MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma. J. Biol. Chem. 2015;290:24678\u201324688. doi: 10.1074/jbc.M115.649004.", "ArticleIdList": ["10.1074/jbc.M115.649004", "PMC4598981", "26286747"]}, {"Citation": "Shen L., Sun C., Li Y., Li X., Sun T., Liu C., Zhou Y., Du Z. MicroRNA-199a-3p Suppresses Glioma Cell Proliferation by Regulating the AKT/MTOR Signaling Pathway. Tumor Biol. 2015;36:6929\u20136938. doi: 10.1007/s13277-015-3409-z.", "ArticleIdList": ["10.1007/s13277-015-3409-z", "PMC4644202", "25854175"]}, {"Citation": "Li W., Wang Y., Liu R., Kasinski A.L., Shen H., Slack F.J., Tang D.G. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic. Front. Cell Dev. Biol. 2021;9:640587. doi: 10.3389/fcell.2021.640587.", "ArticleIdList": ["10.3389/fcell.2021.640587", "PMC7982597", "33763422"]}, {"Citation": "Rathod S.S., Rani S.B., Khan M., Muzumdar D., Shiras A. Tumor Suppressive MiRNA-34a Suppresses Cell Proliferation and Tumor Growth of Glioma Stem Cells by Targeting Akt and Wnt Signaling Pathways. FEBS Open Bio. 2014;4:485\u2013495. doi: 10.1016/j.fob.2014.05.002.", "ArticleIdList": ["10.1016/j.fob.2014.05.002", "PMC4060015", "24944883"]}, {"Citation": "Sasayama T., Tanaka K., Kohmura E. Neurooncology\u2014Newer Developments. IntechOpen; London, UK: 2016. The Roles of MicroRNAs in Glioblastoma Biology and Biomarker.", "ArticleIdList": ["10.5772/63243"]}, {"Citation": "Mazurek M., Litak J., Kamieniak P., Osuchowska I., Maciejewski R., Roli\u0144ski J., Grajkowska W., Grochowski C. Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme. Int. J. Mol. Sci. 2020;21:1507. doi: 10.3390/ijms21041507.", "ArticleIdList": ["10.3390/ijms21041507", "PMC7073212", "32098401"]}, {"Citation": "Wang H., Zhi H., Ma D., Li T. MiR-217 Promoted the Proliferation and Invasion of Glioblastoma by Repressing YWHAG. Cytokine. 2017;92:93\u2013102. doi: 10.1016/j.cyto.2016.12.013.", "ArticleIdList": ["10.1016/j.cyto.2016.12.013", "28126486"]}, {"Citation": "Liang H.Q., Wang R.J., Diao C.F., Li J.W., Su J.L., Zhang S. The PTTG1-Targeting MiRNAs MiR-329, MiR-300, MiR-381, and MiR-655 Inhibit Pituitary Tumor Cell Tumorigenesis and Are Involved in a P53/PTTG1 Regulation Feedback Loop. Oncotarget. 2015;6:29413\u201329427. doi: 10.18632/oncotarget.5003.", "ArticleIdList": ["10.18632/oncotarget.5003", "PMC4745736", "26320179"]}, {"Citation": "Yu X., Zhang Y., Cavazos D., Ma X., Zhao Z., Du L., Pertsemlidis A. MIR-195 Targets Cyclin D3 and Survivin to Modulate the Tumorigenesis of Non-Small Cell Lung Cancer. Cell Death Dis. 2018;9:193. doi: 10.1038/s41419-017-0219-9.", "ArticleIdList": ["10.1038/s41419-017-0219-9", "PMC5833354", "29416000"]}, {"Citation": "Xu Q., Liu L.Z., Yin Y., He J., Li Q., Qian X., You Y., Lu Z., Peiper S.C., Shu Y., et al. Regulatory Circuit of PKM2/NF-\u039aB/MIR-148a/152-Modulated Tumor Angiogenesis and Cancer Progression. Oncogene. 2015;34:5482\u20135493. doi: 10.1038/onc.2015.6.", "ArticleIdList": ["10.1038/onc.2015.6", "25703326"]}, {"Citation": "Ye J., Li L., Feng P., Wan J., Li J. Downregulation of MiR-34a Contributes to the Proliferation and Migration of Laryngeal Carcinoma Cells by Targeting Cyclin D1. Oncol. Rep. 2016;36:390\u2013398. doi: 10.3892/or.2016.4823.", "ArticleIdList": ["10.3892/or.2016.4823", "27220728"]}, {"Citation": "Cao P., Feng Y., Deng M., Li J., Cai H., Meng Q., Fang W., Li Y., Ke J., Long X. MiR-15b Is a Key Regulator of Proliferation and Apoptosis of Chondrocytes from Patients with Condylar Hyperplasia by Targeting IGF1, IGF1R and BCL2. Osteoarthr. Cartil. 2019;27:336\u2013346. doi: 10.1016/j.joca.2018.09.010.", "ArticleIdList": ["10.1016/j.joca.2018.09.010", "30521861"]}, {"Citation": "Kouhkan F., Mobarra N., Soufi-Zomorrod M., Keramati F., Ali Hosseini Rad S.M., Fathi-Roudsari M., Tavakoli R., Hajarizadeh A., Ziaei S., Lahmi R., et al. MicroRNA-129-1 Acts as Tumour Suppressor and Induces Cell Cycle Arrest of GBM Cancer Cells through Targeting IGF2BP3 and MAPK1. J. Med. Genet. 2015;53:24\u201333. doi: 10.1136/jmedgenet-2015-103225.", "ArticleIdList": ["10.1136/jmedgenet-2015-103225", "26510428"]}, {"Citation": "Ouyang Q., Chen G., Zhou J., Li L., Dong Z., Yang R., Xu L., Cui H., Xu M., Yi L. Neurotensin Signaling Stimulates Glioblastoma Cell Proliferation by Upregulating C-Myc and Inhibiting MiR-29b-1 and MiR-129-3p. Neuro. Oncol. 2016;18:216\u2013226. doi: 10.1093/neuonc/nov114.", "ArticleIdList": ["10.1093/neuonc/nov114", "PMC4724174", "26180082"]}, {"Citation": "Ofek P., Calder\u00f3n M., Mehrabadi F.S., Krivitsky A., Ferber S., Tiram G., Yerushalmi N., Kredo-Russo S., Grossman R., Ram Z., et al. Restoring the Oncosuppressor Activity of MicroRNA-34a in Glioblastoma Using a Polyglycerol-Based Polyplex. Nanomed. Nanotechnol. Biol. Med. 2016;12:2201\u20132214. doi: 10.1016/j.nano.2016.05.016.", "ArticleIdList": ["10.1016/j.nano.2016.05.016", "PMC5364374", "27262933"]}, {"Citation": "Zhong Y., Ye Q., Chen C., Wang M., Wang H. Ezh2 Promotes Clock Function and Hematopoiesis Independent of Histone Methyltransferase Activity in Zebrafish. Nucleic Acids Res. 2018;46:3382\u20133399. doi: 10.1093/nar/gky101.", "ArticleIdList": ["10.1093/nar/gky101", "PMC5909462", "29447387"]}, {"Citation": "Shang C., Guo Y., Hong Y., Liu Y.H., Xue Y. MiR-21 up-Regulation Mediates Glioblastoma Cancer Stem Cells Apoptosis and Proliferation by Targeting FASLG. Mol. Biol. Rep. 2015;42:721\u2013727. doi: 10.1007/s11033-014-3820-3.", "ArticleIdList": ["10.1007/s11033-014-3820-3", "25394756"]}, {"Citation": "Wang S., Feng L., Hu B.G., Lu Y.F., Wang W.M., Guo W., Suen C.W., Jiao B.H., Pang J.X., Fu W.M., et al. MiR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-\u039aB Signaling. Mol. Ther.-Nucleic Acids. 2017;8:482\u2013492. doi: 10.1016/j.omtn.2017.07.015.", "ArticleIdList": ["10.1016/j.omtn.2017.07.015", "PMC5560119", "28918048"]}, {"Citation": "Zhang X., Zhang Y., Yang J., Li S., Chen J. Upregulation of MiR-582-5p Inhibits Cell Proliferation, Cell Cycle Progression and Invasion by Targeting Rab27a in Human Colorectal Carcinoma. Cancer Gene Ther. 2015;22:475\u2013480. doi: 10.1038/cgt.2015.44.", "ArticleIdList": ["10.1038/cgt.2015.44", "26384136"]}, {"Citation": "Fu Z.J., Chen Y., Xu Y.Q., Lin M.A., Wen H., Chen Y.T., Pan P.L. Regulation of MiR-30b in Cancer Development, Apoptosis, and Drug Resistance. Open Life Sci. 2022;17:102\u2013106. doi: 10.1515/biol-2022-0017.", "ArticleIdList": ["10.1515/biol-2022-0017", "PMC8886600", "35291564"]}, {"Citation": "Duan K., Ge Y.C., Zhang X.P., Wu S.Y., Feng J.S., Chen S.L., Zhang L., Yuan Z.H., Fu C.H. MiR-34a Inhibits Cell Proliferation in Prostate Cancer by Downregulation of SIRT1 Expression. Oncol. Lett. 2015;10:3223\u20133227. doi: 10.3892/ol.2015.3645.", "ArticleIdList": ["10.3892/ol.2015.3645", "PMC4665267", "26722316"]}, {"Citation": "Zhang Z., Zhou Q., Miao Y., Tian H., Li Y., Feng X., Song X. MiR-429 Induces Apoptosis of Glioblastoma Cell through Bcl-2. Tumor Biol. 2016;37:15607\u201315613. doi: 10.1007/s13277-015-4291-4.", "ArticleIdList": ["10.1007/s13277-015-4291-4", "26511969"]}, {"Citation": "Luo B., Zhang J. MicroRNA-16 Inhibits the Migration and Invasion of Glioma Cell by Targeting Bcl-2 Gene. Trop. J. Pharm. Res. 2020;19:2499\u20132504. doi: 10.4314/tjpr.v19i12.3.", "ArticleIdList": ["10.4314/tjpr.v19i12.3"]}, {"Citation": "Chung H.J., Choi Y.E., Kim E.S., Han Y.H., Park M.J., Bae I.H. MiR-29b Attenuates Tumorigenicity and Stemness Maintenance in Human Glioblastoma Multiforme by Directly Targeting BCL2L2. Oncotarget. 2015;6:18429\u201318444. doi: 10.18632/oncotarget.4384.", "ArticleIdList": ["10.18632/oncotarget.4384", "PMC4621901", "26155940"]}, {"Citation": "Wang L., Liu Y., Yu Z., Gong J., Deng Z., Ren N., Zhong Z., Cai H., Tang Z., Cheng H., et al. Mir-139-5p Inhibits Glioma Cell Proliferation and Progression by Targeting GABRA1. J. Transl. Med. 2021;19:213. doi: 10.1186/s12967-021-02880-9.", "ArticleIdList": ["10.1186/s12967-021-02880-9", "PMC8130534", "34001135"]}, {"Citation": "Cui J., Placzek W.J. Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members. Int. J. Mol. Sci. 2018;19:308. doi: 10.3390/ijms19010308.", "ArticleIdList": ["10.3390/ijms19010308", "PMC5796252", "29361709"]}, {"Citation": "Gao X., Zhu X., Sun Y., Liu J. MicroRNA-141 Inhibits the Self-Renewal of Glioblastoma Stem Cells via Jaggedl. Mol. Med. Rep. 2017;16:167\u2013173. doi: 10.3892/mmr.2017.6598.", "ArticleIdList": ["10.3892/mmr.2017.6598", "PMC5482111", "28535010"]}, {"Citation": "Huang S.X., Zhao Z.Y., Weng G.H., He X.Y., Wu C.J., Fu C.Y., Sui Z.Y., Ma Y.S., Liu T. Upregulation of MiR-181a Suppresses the Formation of Glioblastoma Stem Cells by Targeting the Notch2 Oncogene and Correlates with Good Prognosis in Patients with Glioblastoma Multiforme. Biochem. Biophys. Res. Commun. 2017;486:1129\u20131136. doi: 10.1016/j.bbrc.2017.04.008.", "ArticleIdList": ["10.1016/j.bbrc.2017.04.008", "28389242"]}, {"Citation": "Fm K., La H., Wl D., Es D., Hua Y., Hao L., Cy P., Tj M., Ma Q., Ritner C. Differentiation Programs in Glioblastoma. Cold Spring Harb. Lab. Press. 2015;2:25838542. doi: 10.1101/gad.257394.114.732.", "ArticleIdList": ["10.1101/gad.257394.114.732"]}, {"Citation": "Wong H.K.A., El Fatimy R., Onodera C., Wei Z., Yi M., Mohan A., Gowrisankaran S., Karmali P., Marcusson E., Wakimoto H., et al. The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma. Mol. Ther. 2015;23:1234\u20131247. doi: 10.1038/mt.2015.72.", "ArticleIdList": ["10.1038/mt.2015.72", "PMC4817797", "25903473"]}, {"Citation": "Tan W., Liu B., Qu S., Liang G., Luo W., Gong C. MicroRNAs and Cancer: Key Paradigms in Molecular Therapy (Review) Oncol. Lett. 2018;15:2735\u20132742. doi: 10.3892/ol.2017.7638.", "ArticleIdList": ["10.3892/ol.2017.7638", "PMC5778870", "29434998"]}, {"Citation": "Wang Z., Xue Y., Wang P., Zhu J., Ma J. MIR-608 Inhibits the Migration and Invasion of Glioma Stem Cells by Targeting Macrophage Migration Inhibitory Factor. Oncol. Rep. 2016;35:2733\u20132742. doi: 10.3892/or.2016.4652.", "ArticleIdList": ["10.3892/or.2016.4652", "26935642"]}, {"Citation": "Zhao B., Wang Y., Fang X., Gu L., Zhang C. Targeting KLF6. Animals. 2021;11:2\u20139.", "ArticleIdList": ["PMC8532817", "34680020"]}, {"Citation": "Yao Y.L., Ma J., Wang P., Xue Y.X., Li Z., Zhao L.N., Li Z.Q., Feng T.D., Liu Y.H. MiR-101 Acts as a Tumor Suppressor by Targeting Kruppel-like Factor 6 in Glioblastoma Stem Cells. CNS Neurosci. Ther. 2015;21:40\u201351. doi: 10.1111/cns.12321.", "ArticleIdList": ["10.1111/cns.12321", "PMC6495804", "25230316"]}, {"Citation": "Yao Y., Ma J., Xue Y., Wang P., Li Z., Li Z., Hu Y., Shang X., Liu Y. MiR-449a Exerts Tumor-Suppressive Functions in Human Glioblastoma by Targeting Myc-Associated Zinc-Finger Protein. Mol. Oncol. 2015;9:640\u2013656. doi: 10.1016/j.molonc.2014.11.003.", "ArticleIdList": ["10.1016/j.molonc.2014.11.003", "PMC5528701", "25487955"]}, {"Citation": "Xi Z., Wang P., Xue Y., Shang C., Liu X., Ma J., Li Z., Li Z., Bao M., Liu Y. Overexpression of MiR-29a Reduces the Oncogenic Properties of Glioblastoma Stem Cells by Downregulating Quaking Gene Isoform 6. Oncotarget. 2017;8:24949\u201324963. doi: 10.18632/oncotarget.15327.", "ArticleIdList": ["10.18632/oncotarget.15327", "PMC5421901", "28212562"]}, {"Citation": "Shi Y., Chen C., Yu S.Z., Liu Q., Rao J., Zhang H.R., Xiao H.L., Fu T.W., Long H., He Z.C., et al. MiR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma. Clin. Cancer Res. 2015;21:4004\u20134013. doi: 10.1158/1078-0432.CCR-14-2807.", "ArticleIdList": ["10.1158/1078-0432.CCR-14-2807", "26023083"]}, {"Citation": "Wang Y., Chen R., Zhou X., Guo R., Yin J., Li Y., Ma G. MiR-137: A Novel Therapeutic Target for Human Glioma. Mol. Ther.-Nucleic Acids. 2020;21:614\u2013622. doi: 10.1016/j.omtn.2020.06.028.", "ArticleIdList": ["10.1016/j.omtn.2020.06.028", "PMC7393316", "32736290"]}, {"Citation": "Li Q., Cheng Q., Chen Z., Peng R., Chen R., Ma Z., Wan X., Liu J., Meng M., Peng Z., et al. MicroRNA-663 Inhibits the Proliferation, Migration and Invasion of Glioblastoma Cells via Targeting TGF-1. Oncol. Rep. 2016;35:1125\u20131134. doi: 10.3892/or.2015.4432.", "ArticleIdList": ["10.3892/or.2015.4432", "26717894"]}, {"Citation": "He X., Liu Z., Peng Y., Yu C. MicroRNA-181c Inhibits Glioblastoma Cell Invasion, Migration and Mesenchymal Transition by Targeting TGF-\u03b2 Pathway. Biochem. Biophys. Res. Commun. 2016;469:1041\u20131048. doi: 10.1016/j.bbrc.2015.12.021.", "ArticleIdList": ["10.1016/j.bbrc.2015.12.021", "26682928"]}, {"Citation": "Jiang C., Shen F., Du J., Hu Z., Li X., Su J., Wang X., Huang X. MicroRNA-564 Is Downregulated in Glioblastoma and Inhibited Proliferation and Invasion of Glioblastoma Cells by Targeting TGF-\u03921. Oncotarget. 2016;7:56200\u201356208. doi: 10.18632/oncotarget.8987.", "ArticleIdList": ["10.18632/oncotarget.8987", "PMC5302907", "27621042"]}, {"Citation": "Wei F., Wang Q., Su Q., Huang H., Luan J., Xu X., Wang J. MiR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2. Cell. Mol. Neurobiol. 2016;36:1389\u20131397. doi: 10.1007/s10571-016-0338-3.", "ArticleIdList": ["10.1007/s10571-016-0338-3", "26858153"]}, {"Citation": "Hu S., Chen H., Zhang Y., Wang C., Liu K., Wang H., Luo J. MicroRNA-520c Inhibits Glioma Cell Migration and Invasion by the Suppression of Transforming Growth Factor-\u03b2 Receptor Type 2. Oncol. Rep. 2017;37:1691\u20131697. doi: 10.3892/or.2017.5421.", "ArticleIdList": ["10.3892/or.2017.5421", "28184932"]}, {"Citation": "Liu X., Li J., Qin F., Dai S. MiR-152 as a Tumor Suppressor MicroRNA: Target Recognition and Regulation in Cancer. Oncol. Lett. 2016;11:3911\u20133916. doi: 10.3892/ol.2016.4509.", "ArticleIdList": ["10.3892/ol.2016.4509", "PMC4888271", "27313716"]}, {"Citation": "Wang L., Sun H., Wang X., Hou N., Zhao L., Tong D., He K., Yang Y., Song T., Yang J., et al. EGR1 Mediates MiR-203a Suppress the Hepatocellular Carcinoma Cells Progression by Targeting HOXD3 through EGFR Signaling Pathway. Oncotarget. 2016;7:45302\u201345316. doi: 10.18632/oncotarget.9605.", "ArticleIdList": ["10.18632/oncotarget.9605", "PMC5216724", "27244890"]}, {"Citation": "Shea A., Harish V., Afzal Z., Chijioke J., Kedir H., Dusmatova S., Roy A., Ramalinga M., Harris B., Blancato J., et al. MicroRNAs in Glioblastoma Multiforme Pathogenesis and Therapeutics. Cancer Med. 2016;5:1917\u20131946. doi: 10.1002/cam4.775.", "ArticleIdList": ["10.1002/cam4.775", "PMC4971921", "27282910"]}, {"Citation": "Nguyen H.T., Kacimi S.E.O., Nguyen T.L., Suman K.H., Lemus-Martin R., Saleem H., Do D.N. MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology. 2021;10:417. doi: 10.3390/biology10050417.", "ArticleIdList": ["10.3390/biology10050417", "PMC8151274", "34066762"]}, {"Citation": "Wang Z., Wang B., Shi Y., Xu C., Xiao H.L., Ma L.N., Xu S.L., Yang L., Wang Q.L., Dang W.Q., et al. Oncogenic MiR-20a and MiR-106a Enhance the Invasiveness of Human Glioma Stem Cells by Directly Targeting TIMP-2. Oncogene. 2015;34:1407\u20131419. doi: 10.1038/onc.2014.75.", "ArticleIdList": ["10.1038/onc.2014.75", "24704830"]}, {"Citation": "Cai J.J., Qi Z.X., Chen L.C., Yao Y., Gong Y., Mao Y. MiR-124 Suppresses the Migration and Invasion of Glioma Cells in Vitro via Capn4. Oncol. Rep. 2016;35:284\u2013290. doi: 10.3892/or.2015.4355.", "ArticleIdList": ["10.3892/or.2015.4355", "26530859"]}, {"Citation": "Gao Y.F., Zhu T., Chen J., Liu L., Ouyang R. Knockdown of Collagen \u03b1-1(Iii) Inhibits Glioma Cell Proliferation and Migration and Is Regulated by Mir128-3p. Oncol. Lett. 2018;16:1917\u20131923. doi: 10.3892/ol.2018.8830.", "ArticleIdList": ["10.3892/ol.2018.8830", "PMC6036335", "30008884"]}, {"Citation": "Liao H., Bai Y., Qiu S., Zheng L., Huang L., Liu T., Wang X., Liu Y., Xu N., Yan X., et al. MiR-203 Downregulation Is Responsible for Chemoresistance in Human Glioblastoma by Promoting Epithelial-Mesenchymal Transition via SNAI2. Oncotarget. 2015;6:8914\u20138928. doi: 10.18632/oncotarget.3563.", "ArticleIdList": ["10.18632/oncotarget.3563", "PMC4496192", "25871397"]}, {"Citation": "Pang H., Zheng Y., Zhao Y., Xiu X., Wang J. MiR-590-3p Suppresses Cancer Cell Migration, Invasion and Epithelial-Mesenchymal Transition in Glioblastoma Multiforme by Targeting ZEB1 and ZEB2. Biochem. Biophys. Res. Commun. 2015;468:739\u2013745. doi: 10.1016/j.bbrc.2015.11.025.", "ArticleIdList": ["10.1016/j.bbrc.2015.11.025", "26556542"]}, {"Citation": "Xiao B., Zhou X., Ye M., Lv S., Wu M., Liao C., Han L., Kang C., Zhu X. MicroRNA-566 Modulates Vascular Endothelial Growth Factor by Targeting von Hippel-Landau in Human Glioblastoma in Vitro and in Vivo. Mol. Med. Rep. 2016;13:379\u2013385. doi: 10.3892/mmr.2015.4537.", "ArticleIdList": ["10.3892/mmr.2015.4537", "26572705"]}, {"Citation": "Salinas-Vera Y.M., Marchat L.A., Gallardo-Rinc\u00f3n D., Ruiz-Garc\u00eda E., Astudillo-De la Vega H., Echavarr\u00eda-Zepeda R., L\u00f3pez-Camarillo C. AngiomiRs: MicroRNAs Driving Angiogenesis in Cancer (Review) Int. J. Mol. Med. 2019;43:657\u2013670. doi: 10.3892/ijmm.2018.4003.", "ArticleIdList": ["10.3892/ijmm.2018.4003", "30483765"]}, {"Citation": "Mazurek M., Grochowski C., Litak J., Osuchowska I., Maciejewski R., Kamieniak P. Recent Trends of MicroRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme. Int. J. Mol. Sci. 2020;21:3046. doi: 10.3390/ijms21093046.", "ArticleIdList": ["10.3390/ijms21093046", "PMC7246719", "32349263"]}, {"Citation": "Marisetty A., Wei J., Kong L.Y., Ott M., Fang D., Sabbagh A., Heimberger A.B. Mir-181 Family Modulates Osteopontin in Glioblastoma Multiforme. Cancers. 2020;12:3813. doi: 10.3390/cancers12123813.", "ArticleIdList": ["10.3390/cancers12123813", "PMC7765845", "33348707"]}, {"Citation": "Liu J., Xu J., Li H., Sun C., Yu L., Li Y., Shi C., Zhou X., Bian X., Ping Y., et al. MiR-146b-5p Functions as a Tumor Suppressor by Targeting TRAF6 and Predicts the Prognosis of Human Gliomas. Oncotarget. 2015;6:29129. doi: 10.18632/oncotarget.4895.", "ArticleIdList": ["10.18632/oncotarget.4895", "PMC4745716", "26320176"]}, {"Citation": "Kosaka A., Ohkuri T., Ikeura M., Kohanbash G., Okada H. Transgene-Derived Overexpression of MiR-17-92 in CD8+ T-Cells Confers Enhanced Cytotoxic Activity. Biochem. Biophys. Res. Commun. 2015;458:549\u2013554. doi: 10.1016/j.bbrc.2015.02.003.", "ArticleIdList": ["10.1016/j.bbrc.2015.02.003", "PMC4355048", "25677619"]}, {"Citation": "Yeh M., Wang Y.Y., Yoo J.Y., Oh C., Otani Y., Kang J.M., Park E.S., Kim E., Chung S., Jeon Y.J., et al. MicroRNA-138 Suppresses Glioblastoma Proliferation through Downregulation of CD44. Sci. Rep. 2021;11:9219. doi: 10.1038/s41598-021-88615-8.", "ArticleIdList": ["10.1038/s41598-021-88615-8", "PMC8080729", "33911148"]}, {"Citation": "Zingoni A., Molfetta R., Fionda C., Soriani A., Paolini R., Cippitelli M., Cerboni C., Santoni A. NKG2D and Its Ligands: \u201cOne for All, All for One\u201d. Front. Immunol. 2018;9:476. doi: 10.3389/fimmu.2018.00476.", "ArticleIdList": ["10.3389/fimmu.2018.00476", "PMC5890157", "29662484"]}, {"Citation": "Yin J., Shi Z., Wei W., Lu C., Wei Y., Yan W., Li R., Zhang J., You Y., Wang X. MiR-181b Suppress Glioblastoma Multiforme Growth through Inhibition of SP1-Mediated Glucose Metabolism. Cancer Cell Int. 2020;20:69. doi: 10.1186/s12935-020-1149-7.", "ArticleIdList": ["10.1186/s12935-020-1149-7", "PMC7057587", "32158359"]}, {"Citation": "Kang K., Zhang J., Zhang X., Chen Z. MicroRNA-326 Inhibits Melanoma Progression by Targeting KRAS and Suppressing the AKT and ERK Signalling Pathways. Oncol. Rep. 2018;39:401\u2013410. doi: 10.3892/or.2017.6074.", "ArticleIdList": ["10.3892/or.2017.6074", "29115540"]}, {"Citation": "Luan W., Wang Y., Chen X., Shi Y., Wang J., Zhang J., Qian J., Li R., Tao T., Wei W., et al. PKM2 Promotes Glucose Metabolism and Cell Growth in Gliomas through a Mechanism Involving a Let-7a/c-Myc/HnRNPA1 Feedback Loop. Oncotarget. 2015;6:13006\u201313018. doi: 10.18632/oncotarget.3514.", "ArticleIdList": ["10.18632/oncotarget.3514", "PMC4536995", "25948776"]}, {"Citation": "Gu J.J., Gao G.Z., Zhang S.M. MIR-218 Inhibits the Tumorgenesis and Proliferation of Glioma Cells by Targeting Robo1. Cancer Biomark. 2016;16:309\u2013317. doi: 10.3233/CBM-160568.", "ArticleIdList": ["10.3233/CBM-160568", "26889813"]}, {"Citation": "Adhami M., MotieGhader H., Haghdoost A.A., Afshar R.M., Sadeghi B. Gene Co-Expression Network Approach for Predicting Prognostic MicroRNA Biomarkers in Different Subtypes of Breast Cancer. Genomics. 2020;112:135\u2013143. doi: 10.1016/j.ygeno.2019.01.010.", "ArticleIdList": ["10.1016/j.ygeno.2019.01.010", "30735795"]}, {"Citation": "Liu Z., Jiang Z., Huang J., Huang S. MiR-7 Inhibits Glioblastoma Growth by Simultaneously Interfering with the PI3K/ATK and Raf / MEK / ERK Pathways. Int. J. Oncol. 2014;44:1571\u20131580. doi: 10.3892/ijo.2014.2322.", "ArticleIdList": ["10.3892/ijo.2014.2322", "24603851"]}, {"Citation": "Aloizou A., Pateraki G., Siokas V., Mentis A.A., Liampas I., Lazopoulos G., Kovatsi L., Mitsias P.D., Bogdanos D.P., Paterakis K., et al. The Role of MiRNA-21 in Gliomas: Hope for a Novel Therapeutic Intervention? Toxicol. Rep. 2020;7:1514\u20131530. doi: 10.1016/j.toxrep.2020.11.001.", "ArticleIdList": ["10.1016/j.toxrep.2020.11.001", "PMC7677650", "33251119"]}, {"Citation": "Wang G.B., Liu J.H., Hu J., Xue K. MiR-21 Enhanced Glioma Cells Resistance to Carmustine via Decreasing Spry2 Expression. Eur. Rev. Med. Pharmacol. Sci. 2017;21:5065\u20135071. doi: 10.26355/EURREV_201711_13819.", "ArticleIdList": ["10.26355/EURREV_201711_13819", "29228450"]}, {"Citation": "Bhere D., Arghiani N., Lechtich E.R., Yao Y. Simultaneous Downregulation of MiR-21 and Upregulation of MiR-7 Has Anti-Tumor Efficacy. Sci. Rep. 2020;10:1779. doi: 10.1038/s41598-020-58072-w.", "ArticleIdList": ["10.1038/s41598-020-58072-w", "PMC7000780", "32019988"]}, {"Citation": "M\u00fcller P., Abdel Gaber S.A., Zimmermann W., Wittig R., Stepp H. ABCG2 Influence on the Efficiency of Photodynamic Therapy in Glioblastoma Cells. J. Photochem. Photobiol. B Biol. 2020;210:111963. doi: 10.1016/j.jphotobiol.2020.111963.", "ArticleIdList": ["10.1016/j.jphotobiol.2020.111963", "32795847"]}, {"Citation": "Jeon H.M., Sohn Y.W., Oh S.Y., Kim S.H., Beck S., Kim S., Kim H. ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing MiR-9*-Mediated Suppression of SOX2. Cancer Res. 2011;71:3410\u20133421. doi: 10.1158/0008-5472.CAN-10-3340.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-3340", "21531766"]}, {"Citation": "Tang H., Wang Z., Liu Q., Liu X., Wu M., Li G. Disturbing MiR-182 and -381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4. PLoS ONE. 2014;9:e84146. doi: 10.1371/journal.pone.0084146.", "ArticleIdList": ["10.1371/journal.pone.0084146", "PMC3880275", "24404152"]}, {"Citation": "Wang Z., Yang J., Xu G., Wang W., Liu C., Yang H., Yu Z., Lei Q., Xiao L., Xiong J., et al. Targeting MiR-381-NEFL Axis Sensitizes Glioblastoma Cells to Temozolomide by Regulating Stemness Factors and Multidrug Resistance Factors. Oncotarget. 2015;6:3147\u20133164. doi: 10.18632/oncotarget.3061.", "ArticleIdList": ["10.18632/oncotarget.3061", "PMC4413644", "25605243"]}, {"Citation": "Li Y., Liu Y., Ren J., Deng S., Yi G., Guo M., Shu S., Zhao L., Peng Y., Qi S. MiR-1268a Regulates ABCC1 Expression to Mediate Temozolomide Resistance in Glioblastoma. J. Neurooncol. 2018;138:499\u2013508. doi: 10.1007/s11060-018-2835-3.", "ArticleIdList": ["10.1007/s11060-018-2835-3", "29876787"]}, {"Citation": "Wang L., Jiang C.F., Li D.M., Ge X., Shi Z.M., Li C.Y., Liu X., Yin Y., Zhen L., Liu L.Z., et al. MicroRNA-497 Inhibits Tumor Growth and Increases Chemosensitivity to 5-Fluorouracil Treatment by Targeting KSR1. Oncotarget. 2016;7:2660\u20132671. doi: 10.18632/oncotarget.6545.", "ArticleIdList": ["10.18632/oncotarget.6545", "PMC4823062", "26673620"]}, {"Citation": "Yang L., Li N., Yan Z., Li C., Zhao Z. MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133+ Glioblastoma Stem Cells. J. Mol. Neurosci. 2018;66:369\u2013377. doi: 10.1007/s12031-018-1177-0.", "ArticleIdList": ["10.1007/s12031-018-1177-0", "30267383"]}, {"Citation": "Li D.M., Chen Q.D., Wei G.N., Wei J., Yin J.X., He J.H., Ge X., Shi Z.M. Hypoxia-Induced MiR-137 Inhibition Increased Glioblastoma Multiforme Growth and Chemoresistance Through LRP6. Front. Oncol. 2021;10:611699. doi: 10.3389/fonc.2020.611699.", "ArticleIdList": ["10.3389/fonc.2020.611699", "PMC7946983", "33718112"]}, {"Citation": "Miroshnichenko S., Patutina O. Enhanced Inhibition of Tumorigenesis Using Combinations of MiRNA-Targeted Therapeutics. Front. Pharmacol. 2019;10:488. doi: 10.3389/fphar.2019.00488.", "ArticleIdList": ["10.3389/fphar.2019.00488", "PMC6531850", "31156429"]}, {"Citation": "Jesionek-Kupnicka D., Braun M., Tr\u0105bska-Kluch B., Czech J., Szybka M., Szyma\u0144ska B., Kulczycka-Wojdala D., Bie\u0144kowski M., Kordek R., Zawlik I. MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients. Arch. Med Sci. 2019;15:504\u2013512. doi: 10.5114/aoms.2017.69374.", "ArticleIdList": ["10.5114/aoms.2017.69374", "PMC6425218", "30899304"]}, {"Citation": "Zhang X., Yu J., Zhao C., Ren H., Yuan Z., Zhang B., Zhuang J., Wang J., Feng B. MiR-181b-5p Modulates Chemosensitivity of Glioma Cells to Temozolomide by Targeting Bcl-2. Biomed. Pharmacother. 2019;109:2192\u20132202. doi: 10.1016/j.biopha.2018.11.074.", "ArticleIdList": ["10.1016/j.biopha.2018.11.074", "30551476"]}, {"Citation": "Wu Y.H., Yao Y., Yun Y.L., Wang M.L., Zhu R.X. MicroRNA-302c Enhances the Chemosensitivity of Human Glioma Cells to Temozolomide by Suppressing P-Gp Expression. Biosci. Rep. 2019;39:BSR20190421. doi: 10.1042/BSR20190421.", "ArticleIdList": ["10.1042/BSR20190421", "PMC6744599", "31409725"]}, {"Citation": "Milani R., Brognara E., Fabbri E., Manicardi A., Corradini R., Finotti A., Gasparello J., Borgatti M., Cosenza L.C., Lampronti I., et al. Targeting MiR-155-5p and MiR-221-3p by Peptide Nucleic Acids Induces Caspase-3 Activation and Apoptosis in Temozolomide-resistant T98G Glioma Cells. Int. J. Oncol. 2019;55:59\u201368. doi: 10.3892/ijo.2019.4810.", "ArticleIdList": ["10.3892/ijo.2019.4810", "PMC6561624", "31180529"]}, {"Citation": "Ananta J.S., Paulmurugan R., Massoud T.F. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells. Mol. Pharm. 2015;12:4509\u20134517. doi: 10.1021/acs.molpharmaceut.5b00694.", "ArticleIdList": ["10.1021/acs.molpharmaceut.5b00694", "26559642"]}, {"Citation": "Ma W., Cui Y., Liu M., Tan Z., Jiang Y. Downregulation of MiR-125b Promotes Resistance of Glioma Cells to TRAIL through Overexpression of Tafazzin Which Is a Mitochondrial Protein. Aging. 2019;11:2670\u20132680. doi: 10.18632/aging.101939.", "ArticleIdList": ["10.18632/aging.101939", "PMC6535077", "31056533"]}, {"Citation": "Shirjang S., Mansoori B., Asghari S., Duijf P.H., Mohammadi A., Gjerstorff M., Baradaran B. Corrigendum to \u201cMicroRNAs in Cancer Cell Death Pathways: Apoptosis and Necroptosis\u201d [Free Radic. Biol. Med. 139 (2019) 1\u201315] Free Radic. Biol. Med. 2020;146:402. doi: 10.1016/j.freeradbiomed.2019.06.014.", "ArticleIdList": ["10.1016/j.freeradbiomed.2019.06.014", "31230880"]}, {"Citation": "Rezaei T., Hejazi M., Mansoori B., Mohammadi A., Amini M., Mosafer J., Rezaei S., Mokhtarzadeh A., Baradaran B. MicroRNA-181a Mediates the Chemo-Sensitivity of Glioblastoma to Carmustine and Regulates Cell Proliferation, Migration, and Apoptosis. Eur. J. Pharmacol. 2020;888:173483. doi: 10.1016/j.ejphar.2020.173483.", "ArticleIdList": ["10.1016/j.ejphar.2020.173483", "32810491"]}, {"Citation": "Mondal P., Meeran S.M. MicroRNAs in Cancer Chemoresistance: The Sword and the Shield. Non-Coding RNA Res. 2021;6:200\u2013210. doi: 10.1016/j.ncrna.2021.12.001.", "ArticleIdList": ["10.1016/j.ncrna.2021.12.001", "PMC8669341", "34977437"]}, {"Citation": "Lee S.Y. Temozolomide Resistance in Glioblastoma Multiforme. Genes Dis. 2016;3:198\u2013210. doi: 10.1016/j.gendis.2016.04.007.", "ArticleIdList": ["10.1016/j.gendis.2016.04.007", "PMC6150109", "30258889"]}, {"Citation": "Tan A.C., Ashley D.M., L\u00f3pez G.Y., Malinzak M., Friedman H.S., Khasraw M. Management of Glioblastoma: State of the Art and Future Directions. CA Cancer J. Clin. 2020;70:299\u2013312. doi: 10.3322/caac.21613.", "ArticleIdList": ["10.3322/caac.21613", "32478924"]}, {"Citation": "Alnahhas I., Alsawas M., Rayi A., Palmer J.D., Raval R., Ong S., Giglio P., Murad M.H., Puduvalli V. Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-Analysis. Neuro-Oncol. Adv. 2020;2:vdaa082. doi: 10.1093/noajnl/vdaa082.", "ArticleIdList": ["10.1093/noajnl/vdaa082", "PMC7596890", "33150334"]}, {"Citation": "Singh N., Miner A., Hennis L., Mittal S. Mechanisms of Temozolomide Resistance in Glioblastoma\u2014A Comprehensive Review. Cancer Drug Resist. 2021;4:17\u201343. doi: 10.20517/cdr.2020.79.", "ArticleIdList": ["10.20517/cdr.2020.79", "PMC8319838", "34337348"]}, {"Citation": "Yang L., Ma Y., Xin Y., Han R., Li R., Hao X. Role of the MicroRNA 181 Family in Glioma Development. Mol. Med. Rep. 2018;17:322\u2013329. doi: 10.3892/mmr.2017.7895.", "ArticleIdList": ["10.3892/mmr.2017.7895", "29115595"]}, {"Citation": "Nie E., Jin X., Wu W., Yu T., Zhou X., Shi Z., Zhang J., Liu N., You Y. MiR-198 Enhances Temozolomide Sensitivity in Glioblastoma by Targeting MGMT. J. Neurooncol. 2017;133:59\u201368. doi: 10.1007/s11060-017-2425-9.", "ArticleIdList": ["10.1007/s11060-017-2425-9", "28425046"]}, {"Citation": "Gao Y.T., Chen X.B., Liu H.L. Up-Regulation of MiR-370-3p Restores Glioblastoma Multiforme Sensitivity to Temozolomide by Influencing MGMT Expression. Sci. Rep. 2016;6:32972. doi: 10.1038/srep32972.", "ArticleIdList": ["10.1038/srep32972", "PMC5011744", "27595933"]}, {"Citation": "Serrano-Heras G., Castro-Robles B., Romero-S\u00e1nchez C.M., Carri\u00f3n B., Barbella-Aponte R., Sandoval H., Segura T. Involvement of N-Methylpurine DNA Glycosylase in Resistance to Temozolomide in Patient-Derived Glioma Cells. Sci. Rep. 2020;10:22185. doi: 10.1038/s41598-020-78868-0.", "ArticleIdList": ["10.1038/s41598-020-78868-0", "PMC7747563", "33335215"]}, {"Citation": "Zeng A., Wei Z., Yan W., Yin J., Huang X., Zhou X., Li R., Shen F., Wu W., Wang X., et al. Exosomal Transfer of MiR-151a Enhances Chemosensitivity to Temozolomide in Drug-Resistant Glioblastoma. Volume 436. Elsevier B.V.; Amsterdam, The Netherlands: 2018.", "ArticleIdList": ["30102952"]}, {"Citation": "Asadzadeh Z., Duijf P.H.G., Asgarzadeh K.H. MicroRNAs in Cancer Stem Cells: Biology, Pathways, and Therapeutic Opportunities. J. Cell. Physiol. 2018;234:10002\u201310017. doi: 10.1002/jcp.27885.", "ArticleIdList": ["10.1002/jcp.27885", "30537109"]}, {"Citation": "Jiapaer S., Furuta T., Tanaka S., Kitabayashi T., Nakada M. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma. Neurol. Med. Chir. 2018;58:405\u2013421. doi: 10.2176/nmc.ra.2018-0141.", "ArticleIdList": ["10.2176/nmc.ra.2018-0141", "PMC6186761", "30249919"]}, {"Citation": "Cheng Z.X., Yin W.B., Wang Z.Y. MicroRNA-132 Induces Temozolomide Resistance and Promotes the Formation of Cancer Stem Cell Phenotypes by Targeting Tumor Suppressor Candidate 3 in Glioblastoma. Int. J. Mol. Med. 2017;40:1307\u20131314. doi: 10.3892/ijmm.2017.3124.", "ArticleIdList": ["10.3892/ijmm.2017.3124", "PMC5627876", "28901390"]}, {"Citation": "Mahinfar P., Baradaran B., Davoudian S., Vahidian F., Cho W.C.S., Mansoori B. Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma. Genes. 2021;12:455. doi: 10.3390/genes12030455.", "ArticleIdList": ["10.3390/genes12030455", "PMC8004794", "33806782"]}, {"Citation": "Wang L., Su J., Zhao Z., Hou Y., Yin X., Zheng N., Zhou X., Yan J., Xia J., Wang Z. MiR-26b Reverses Temozolomide Resistance via Targeting Wee1 in Glioma Cells. Cell Cycle. 2017;16:1954\u20131964. doi: 10.1080/15384101.2017.1367071.", "ArticleIdList": ["10.1080/15384101.2017.1367071", "PMC5638394", "28898169"]}, {"Citation": "Li X., Wang H., Wu Z., Yang T., Zhao Z., Chen G., Xie X., Li B., Wei Y., Huang Y., et al. MiR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma. Cell. Mol. Neurobiol. 2015;10:679\u2013687. doi: 10.1007/s10571-015-0163-0.", "ArticleIdList": ["10.1007/s10571-015-0163-0", "PMC4477718", "25662849"]}, {"Citation": "Qiao W., Guo B., Zhou H., Xu W., Chen Y., Liang Y., Dong B. MiR-124 Suppresses Glioblastoma Growth and Potentiates Chemosensitivity by Inhibiting AURKA. Biochem. Biophys. Res. Commun. 2017;486:43\u201348. doi: 10.1016/j.bbrc.2017.02.120.", "ArticleIdList": ["10.1016/j.bbrc.2017.02.120", "28242198"]}, {"Citation": "Munoz J.L., Rodriguez-Cruz V., Ramkissoon S.H., Ligon K.L., Greco S.J., Rameshwar P. Temozolomide Resistance in Glioblastoma Occurs by MiRNA-9-Targeted PTCH1, Independent of Sonic Hedgehog Level. Oncotarget. 2015;6:1190\u20131201. doi: 10.18632/oncotarget.2778.", "ArticleIdList": ["10.18632/oncotarget.2778", "PMC4359226", "25595896"]}, {"Citation": "Chen P.H., Cheng C.H., Shih C.M., Ho K.H., Lin C.W., Lee C.C., Liu A.J., Chang C.K., Chen K.C. The Inhibition of MicroRNA-128 on IGF-1-Activating MTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. PLoS ONE. 2016;11:e167096. doi: 10.1371/journal.pone.0167096.", "ArticleIdList": ["10.1371/journal.pone.0167096", "PMC5125683", "27893811"]}, {"Citation": "Toraih E.A., Aly N.M., Abdallah H.Y., Al-Qahtani S.A., Shaalan A.A.M., Hussein M.H., Fawzy M.S. MicroRNA\u2013Target Cross-Talks: Key Players in Glioblastoma Multiforme. Tumor Biol. 2017;39 doi: 10.1177/1010428317726842.", "ArticleIdList": ["10.1177/1010428317726842", "29110584"]}, {"Citation": "Liu Y., Yang L., Liao F., Wang W., Wang Z.F. MiR-450a-5p Strengthens the Drug Sensitivity of Gefitinib in Glioma Chemotherapy via Regulating Autophagy by Targeting EGFR. Oncogene. 2020;39:6190\u20136202. doi: 10.1038/s41388-020-01422-9.", "ArticleIdList": ["10.1038/s41388-020-01422-9", "PMC7515841", "32820249"]}, {"Citation": "Oprita A., Baloi S.C., Staicu G.A., Alexandru O., Tache D.E., Danoiu S., Micu E.S., Sevastre A.S. Updated Insights on EGFR Signaling Pathways in Glioma. Int. J. Mol. Sci. 2021;22:587. doi: 10.3390/ijms22020587.", "ArticleIdList": ["10.3390/ijms22020587", "PMC7827907", "33435537"]}, {"Citation": "Chen Y., Li R., Pan M., Shi Z., Yan W., Liu N., You Y., Zhang J., Wang X. MiR-181b Modulates Chemosensitivity of Glioblastoma Multiforme Cells to Temozolomide by Targeting the Epidermal Growth Factor Receptor. J. Neurooncol. 2017;133:477\u2013485. doi: 10.1007/s11060-017-2463-3.", "ArticleIdList": ["10.1007/s11060-017-2463-3", "28501897"]}, {"Citation": "Yin J., Zeng A., Zhang Z., Shi Z., Yan W., You Y. Exosomal Transfer of MiR-1238 Contributes to Temozolomide-Resistance in Glioblastoma. EBioMedicine. 2019;42:238\u2013251. doi: 10.1016/j.ebiom.2019.03.016.", "ArticleIdList": ["10.1016/j.ebiom.2019.03.016", "PMC6491393", "30917935"]}, {"Citation": "Zhang J., Zhang J., Zhang J., Qiu W., Xu S., Yu Q., Liu C., Wang Y., Lu A., Zhang J., et al. MicroRNA-625 Inhibits the Proliferation and Increases the Chemosensitivity of Glioma by Directly Targeting AKT2. Am. J. Cancer Res. 2017;7:1835\u20131849.", "ArticleIdList": ["PMC5622219", "28979807"]}, {"Citation": "Li S., Zeng A., Hu Q., Yan W., Liu Y., You Y. MiR-423-5p Contributes to a Malignant Phenotype and Temozolomide Chemoresistance in Glioblastomas. Neuro. Oncol. 2017;19:55\u201365. doi: 10.1093/neuonc/now129.", "ArticleIdList": ["10.1093/neuonc/now129", "PMC5193021", "27471108"]}, {"Citation": "Luo W., Yan D., Song Z., Zhu X., Liu X., Li X., Zhao S. MiR-126-3p Sensitizes Glioblastoma Cells to Temozolomide by Inactivating Wnt/\u03b2-Catenin Signaling via Targeting SOX2. Life Sci. 2019;226:98\u2013106. doi: 10.1016/j.lfs.2019.04.023.", "ArticleIdList": ["10.1016/j.lfs.2019.04.023", "30980849"]}, {"Citation": "Zhou Y., Liu Y., Hu C., Jiang Y. MicroRNA-16 Inhibits the Proliferation, Migration and Invasion of Glioma Cells by Targeting Sal-like Protein 4. Int. J. Mol. Med. 2016;38:1768\u20131776. doi: 10.3892/ijmm.2016.2775.", "ArticleIdList": ["10.3892/ijmm.2016.2775", "27748823"]}, {"Citation": "Ye Q., Liu K., Shen Q., Li Q., Hao J., Han F., Jiang R.W. Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids. Front. Oncol. 2019;9:487. doi: 10.3389/fonc.2019.00487.", "ArticleIdList": ["10.3389/fonc.2019.00487", "PMC6581719", "31245292"]}, {"Citation": "Yang M., Li H., Li Y., Ruan Y., Quan C. Identification of Genes and Pathways Associated with MDR in MCF-7/MDR Breast Cancer Cells by RNA-Seq Analysis. Mol. Med. Rep. 2018;17:6211\u20136226. doi: 10.3892/mmr.2018.8704.", "ArticleIdList": ["10.3892/mmr.2018.8704", "PMC5928598", "29512753"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "23"}, {"Year": "2022", "Month": "6", "Day": "20"}, {"Year": "2022", "Month": "6", "Day": "25"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "1", "Minute": "4"}, {"Year": "2022", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["35804989", "PMC9265057", "10.3390/cancers14133217", "cancers14133217"]}}], "PubmedBookArticle": []}